Rodman David Malcom bought MLYS
March 13, 2026 · Form 4 insider transaction
Rodman David Malcom bought 3,542 shares of Mineralys Therapeutics, Inc. at $10.20 per share, a transaction worth $36.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,542
Price
$10.20
Total value
$36.1K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 13, 2026
Filing dateMarch 16, 2026
Shares owned after86,031
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.